Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurate |
---|---|
Date Designated: | 10/21/2010 |
Orphan Designation: | Treatment of pulmonary arterial hypertension |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Forest Laboratories, Inc. Harborside Financial Center Plaza V Jersey City, New Jersey 07311 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-